BEAM THERAPEUTICS
Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology. It is pioneering the use of base editing, a potential new class of precision genetic medicines, with a vision of providing life-long cures to patients suffering from serious diseases. This technology enables a new class of genetic medicines that targets a single base in the genome without making a double-stranded break in the dna.
BEAM THERAPEUTICS
Industry:
Biotechnology Genetics Medical Therapeutics
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.beamtx.com
Total Employee:
251+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
689 M USD
Technology used in webpage:
Domain Not Resolving Amazon Amazon Virginia Region COVID-19 Ruby On Rails Token New Relic Envoy Amazon Elastic Load Balancing Akamai Hosted Microsoft Ajax Content Delivery Network
Similar Organizations
Ascidian Therapeutics
Ascidian Therapeutics is a biotechnology company that focuses on medical and clinical gene therapy.
Evogene
Evogene is a biotechnology company developing novel products for life science markets through the use of a unique CPB platform.
Genome Medical
Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.
Maze Therapeutics
Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.
Translate Bio
Translate Bio is a biotechnology company that specializes in biotechnology, RNA therapeutics, and rare diseases.
REGENXBIO
REGENXBIO develops adeno-associated viral vector-based therapeutics and research tools, offering NAV, a recombinant AAV-vector.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Terremoto Biosciences
Terremoto Biosciences is a biotechnology company leveraging the power of lysine-based covalency to develop optimized medicines.
Variant Bio
Variant Bio is leveraging the power of human genetic diversity to discover new therapeutics.
Zymeworks
Zymeworks is a computational biotechnology company focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-02-23 | Guide Therapeutics | Guide Therapeutics acquired by Beam Therapeutics | N/A |
Investors List
Perceptive Advisors
Perceptive Advisors investment in Post-IPO Equity - Beam Therapeutics
Casdin Capital
Casdin Capital investment in Post-IPO Equity - Beam Therapeutics
Farallon Capital Management
Farallon Capital Management investment in Post-IPO Equity - Beam Therapeutics
Redmile Group
Redmile Group investment in Post-IPO Equity - Beam Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Post-IPO Equity - Beam Therapeutics
F-Prime Capital
F-Prime Capital investment in Series B - Beam Therapeutics
ARCH Venture Partners
ARCH Venture Partners investment in Series B - Beam Therapeutics
Cormorant Asset Management
Cormorant Asset Management investment in Series B - Beam Therapeutics
Redmile Group
Redmile Group investment in Series B - Beam Therapeutics
Altitude Life Science Ventures
Altitude Life Science Ventures investment in Series B - Beam Therapeutics
Key Employee Changes
Official Site Inspections
http://www.beamtx.com Semrush global rank: 2.07 M Semrush visits lastest month: 9.89 K
- Host name: 13.107.246.35
- IP address: 13.107.246.35
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Beam Therapeutics"
About Us - Beam Therapeutics
Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing lifelong cures to patients suffering from serious diseases. The Beam Team is: a community of fearless innovators; rigorous …See details»
Our Science - Beam Therapeutics
In 2017, Beam Therapeutics was founded by gene editing pioneers with a goal of creating precision genetic medicines with base editing. Beam is a values-driven organization with a vision of delivering lifelong cures to patients suffering from …See details»
Beam Therapeutics - Wikipedia
Beam Therapeutics Inc. is an American biotechnology company conducting research in the field of gene therapies and genome editing. The company is headquartered in Cambridge, Massachusetts. In the development of therapies, the company relies on CRISPR and prime editing, whereby single nucleotides in a DNA sequence can be modified without cutting the DNA, theoretically reducin…See details»
Beam Therapeutics - Crunchbase Company Profile
Contact Email [email protected] Beam Therapeutics is a biotechnology company engaged in creating genetic medicines based on its base editing technology. It is pioneering the use of base editing, a potential new class of precision genetic …See details»
Beam Therapeutics - LinkedIn
Beam Therapeutics | 65,949 followers on LinkedIn. Our vision is to provide life-long cures for patients suffering from serious diseases. | Beam Therapeutics, launched in 2018, is pioneering the ...See details»
Beam Therapeutics to Present Data Across Hematology Franchise ...
Nov 5, 2024 This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. …See details»
Beam Therapeutics Announces Portfolio Prioritization and …
Oct 19, 2023 This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. …See details»
Beam Therapeutics to Participate in Jefferies Global Healthcare ...
May 30, 2024 A live webcast will be available in the investor section of the company's website at www.beamtx.com, and will be archived for 60 days following the presentation. About Beam …See details»
Beam Therapeutics to Participate in 2024 Jefferies London …
Nov 12, 2024 Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. ...See details»
Vice President, Patient Operations - beamtx.com
Nov 21, 2024 Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. …See details»
Beam Therapeutics Highlights Progress Across Base Editing …
Jan 8, 2024 Beam logo. First Patient Dosed and Successfully Engrafted in BEACON Phase 1/2 Trial of BEAM-101 in Patients with Severe Sickle Cell Disease; Significant Enrollment …See details»
Beam Therapeutics to Hold Conference Call to Discuss Third
Oct 29, 2024 Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases. …See details»
Press Release - investors.beamtx.com
May 17, 2023 This has the potential to enable a wide range of potential therapeutic editing strategies that Beam is using to advance a diversified portfolio of base editing programs. …See details»
Press Release - investors.beamtx.com
Jan 5, 2021 The live webcast will be available in the investor section of the company's website at www.beamtx.com. The webcast will be archived for 60 days following the presentation. ...See details»
Pipeline - Beam Therapeutics
<p>We seek to potentially cure serious diseases and address significant unmet medical need so that people can reach their full potential. We believe leveraging ex vivo and in vivo …See details»
Beam Therapeutics - YouTube
Beam is a values-driven organization committed to its people, cutting-edge science, and a vision of providing life-long cures to patients suffering from serious diseases.See details»
Curing serious diseases one letter at a time | Beam Therapeutics
To correct the misspelling, we use a new tool called base editing, which works like an eraser and a pencil.By rewriting a single letter, base editors may correct disease-causing point mutations …See details»
Beam Therapeutics to Participate in the Guggenheim Healthcare …
Feb 5, 2024 A live webcast will be available in the investor section of the company's website at www.beamtx.com and will be archived for 60 days following the presentation. About Beam …See details»
Press Release - investors.beamtx.com
CAMBRIDGE, Mass., Oct. 29, 2024 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base …See details»